Terlipressin (drug) in Acute Variceal Bleeding (Liver Disease).
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Acute variceal bleedHealth Condition 2: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2018/02/011992
- Lead Sponsor
- Institute of liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
1) Any patient with only acute esophageal variceal bleeding (as defined by Asian pacific Association for the study of Liver Disease)
2) Informed consent to participate in the study
3) Age 18 to 70 years
Exclusion Criteria
1) Pregnant and lactation
2) Prior treatment with any vasoactive drugs
3) Significant heart or respiratory failure
4) Peripheral arteriopathy clinically significant
5) Previous heart stroke or significant alteration of the Electrocardiogram
6) Hemodynamically unstable
7) Refusal to participate in the study
8) Hypertension
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Re bleeding in both groupTimepoint: 2 Years
- Secondary Outcome Measures
Name Time Method Death in both groupsTimepoint: 2 Years;Terlipressin related complications in both groupsTimepoint: 2 Years